Radioligand Disposition and Metabolism — Key Information in Early Drug Development
- 1 January 1995
- book chapter
- Published by Springer Nature
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Metabolism of the PET ligand [11C]SCH 23390. Identification of two radiolabelled metabolites with HPLCHuman Psychopharmacology: Clinical and Experimental, 1994
- PET examination of [11C]NNC 687 and [11C]NNC 756 as new radioligands for the D1-dopamine receptorPsychopharmacology, 1993
- [11C]NNC 687 and [11C]NNC 756, dopamine D-1 receptor ligands. Preparation, autoradiography and PET investigation in monkeyNuclear Medicine and Biology, 1993
- PET Radiopharmaceutical Metabolism — Plasma Metabolite AnalysisPublished by Springer Nature ,1993
- Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and ClozapineArchives of General Psychiatry, 1992
- Ligand metabolites in plasma during PET‐studies with the 11C‐labelled dopamine antagonists, raclopride, SCH 23390 and N‐methylspiroperidolHuman Psychopharmacology: Clinical and Experimental, 1992
- Synthesis of carbon-11 labelled SCH 39166, a new selective dopamine D-1 receptor ligand, and preliminary PET investigationsInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1991
- Characterization of C-11-SCH 23390 and its possible metabolites in primate blood using high performance liquid chromatographyJournal of Radioanalytical and Nuclear Chemistry, 1988
- PET analysis of human dopamine receptor subtypes using 11C-SCH 23390 and 11C-raclopridePsychopharmacology, 1987
- Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomographyInternational Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes, 1986